Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Ovid Therapeutics Inc. | Director | Stock Option (Right to Buy) | 30K | Feb 22, 2024 | Direct | ||
Codiak BioSciences, Inc. | Director | Common Stock | 8.75K | Feb 16, 2023 | Indirect | ||
Codiak BioSciences, Inc. | Director | Restricted Stock Units | 0 | Feb 16, 2023 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OVID | Ovid Therapeutics Inc. | Feb 22, 2024 | 1 | $0 | 4 | Feb 26, 2024 | Director |
OVID | Ovid Therapeutics Inc. | Feb 23, 2023 | 1 | $0 | 4 | Feb 27, 2023 | Director |
CDAKQ | Codiak BioSciences, Inc. | Feb 16, 2023 | 2 | $0 | 4 | Feb 21, 2023 | Director |
CDAKQ | Codiak BioSciences, Inc. | Jun 17, 2022 | 2 | $0 | 4 | Jun 21, 2022 | Director |
OVID | Ovid Therapeutics Inc. | Apr 8, 2022 | 1 | $0 | 4 | Apr 12, 2022 | Director |
CDAKQ | Codiak BioSciences, Inc. | Feb 16, 2022 | 1 | $0 | 4 | Feb 18, 2022 | Director |
OVID | Ovid Therapeutics Inc. | Feb 3, 2022 | 1 | $0 | 4 | Feb 4, 2022 | Director |
CDAKQ | Codiak BioSciences, Inc. | Jun 18, 2021 | 1 | $0 | 4 | Jun 22, 2021 | Director |
OVID | Ovid Therapeutics Inc. | Jun 11, 2021 | 1 | $0 | 4 | Jun 11, 2021 | Director |
OVID | Ovid Therapeutics Inc. | May 17, 2021 | 1 | $0 | 4 | May 18, 2021 | Director |